Back to Tools
Iktos vs Nimbus Therapeutics
Side-by-side comparison of features, pricing, and ratings
End-to-end autonomous drug discovery platform integrating generative AI with robotic synthesis and testing.
Visit Website
Designing highly selective small molecule medicines for oncology, immunology, and metabolism.
Visit WebsitePricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
5.5k views
6.5k views
Skill Level
Advanced
Advanced
API Available
Platforms
WebAPI
—
Categories
🤖 Automation & Agents🏥 Healthcare
🔬 Research & Education🏥 Healthcare
Features
Chemistry-first generative AI for de novo molecular design
Multi-parametric optimization (potency, ADME, toxicity)
3D constraint inclusion (protein-ligand interactions)
AI-driven retrosynthesis planning (Spaya)
Real-time retrosynthetic route display
Customizable synthesis steps and constraints
Fully automated synthesis, purification, analysis
High-throughput data generation and iteration
In-cellulo biological screening integration
Support for PPI, RNA-protein, molecular glues, PROTACs
Iktos Engine APIs for agentic workflows (May 2026)
Automated ordering of raw materials
Workflow management for DMTA cycles
Target selection with exquisite selectivity
Computational drug design for small molecules
Translational medicine pipeline development
Clinical development of selective inhibitors
SIK2 inhibitor programs for immuno-inflammatory diseases
Oncology small molecule therapeutics
Metabolic disease small molecule programs
Structure-based drug design
Preclinical and translational data generation
Rigorous molecular optimization for selectivity
Integrations
Chemspeed (automated chemical research, announced March 2026)
Various data providers for retrosynthesis (via Spaya)